Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

N Argeris Karabelas

Affiliations

  • at Regenxbio Inc. (RGNX), 2019-06-04
  • Director at Bausch Health Companies Inc. (BHC), 2019-05-03
  • Large Shareholder, Director at Inotek Pharmaceuticals Corp (ITEK), 2015-06-26
  • Director at Human Genome Sciences Inc (HGSI), 2012-08-01
  • Director at Vanda Pharmaceuticals Inc. (VNDA), 2011-06-17
  • Director at Nitromed Inc (NTMD), 2009-04-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VRX $24.65 4,000 Director 20,726 2016-08-11 Filing
ITEK $6.00 603,832 Large Shareholder, Director 2,277,139 2015-02-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VNDA $11.80 200,000 Director 0 2010-03-12 Filing
VNDA $11.03 98,924 Director 200,000 2009-12-15 Filing
VNDA $11.14 130,000 Director 298,924 2009-12-14 Filing
VNDA $11.57 107,200 Director 428,924 2009-12-09 Filing
VNDA $11.30 26,376 Director 536,124 2009-12-08 Filing